Author

Christopher A. Parks

Primary ORCID profile (0000-0002-2772-2965 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Christopher A. ParksiD1 paper · Columbia University Irving Medical Center

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam G. Schrum· 1 shared Diana Gil· 1 shared Larry R. Pease· 1 shared Laura R.E. Becher· 1 shared Megan Abergel· 1 shared Michele M. Hoffmann· 1 shared Shari S. Sutor· 1 shared Svetomir N. Markovic· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Adam G. Schrum

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Public and private human T cell clones respond differentially to HCMV antigen when boosted by CD3 co-potentiation

Laura R.E. Becher, Wendy K. Nevala, Shari S. Sutor, Megan Abergel, Michele M. Hoffmann, Christopher A. Parks, Larry R. Pease, Adam G. Schrum, Svetomir N. Markovic, Diana Gil

This study shows CD3 co-potentiation enhances expansion of public and private T cell clones responding to HCMV antigens, with distinct expansion patterns based on antigen strength and TCR status.

bioRxiv · Jul 8, 2020 · PreprintImmunology